Wright Medical Group

Wright Medical Group NV engages in the provision of medical device products. It operates through the following segments: U.S. Lower Extremities and Biologics; U.S. Upper Extremities; International Extremities and Biologics; and Corporate. The U.S. Lower Extremities and Biologics includes the sale of its lower extremities products, such as joint implants and bone fixation devices for the foot and ankle; and biologics products used to support treatment of damaged or diseased bone, tendons, and soft tissues or to stimulate bone growth. The U.S. Upper Extremities segment focuses on joint implants and bone fixation devices for the shoulder, elbow, wrist, and hand; and products used across several anatomic sites to mechanically repair tissue-to-tissue or tissue-to-bone injuries, and other ancillary products. The International Extremities and Biologics segment covers all lower and upper extremities products, as well as associated biologics products. The Corporate segment reflects general and administrative expenses not specifically associated with other segments. The company was founded by Frank O. Wright in 1950 and is headquartered in Amsterdam, the Netherlands.

Fitbit

Livongo Health Inc

IQ Merger Arbitrage ETF

Red Robin

Tiffany & Co.

Craft Brew Alliance

Merger Arbitrage Analysis And Spread Performance - September 20, 2020

Transitional Pass-Through Payment    Reimburses Hospital Outpatient and Ambulatory Surgical Centers for Incremental Cost of AUGMENT in Hindfoot and Ankle Fusion Procedures  

Wright Medical Group N.V. Announces Update to Medicare Transitional Device Pass-Through Payment for AUGMENT® Regenerative Solutions

Mayo Clinic Performs First-Ever Shoulder Procedure Utilizing 3-D, Holographic Views Displayed by Mixed Reality System Mayo Clinic Performs First-Ever Shoulder Procedure Utilizing 3-D, Holographic Views Displayed by Mixed Reality System

Wright Medical Group N.V. Announces First Shoulder Arthroplasty Procedure Using BLUEPRINT™ Mixed Reality Technology

Wright Medical (WMGI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Wright Medical Group (WMGI) to Report Q1 Results: Wall Street Expects Earnings Growth

Wright Medical Group: 10% Spread Looks Attractive

Wright Medical (WMGI) reported earnings 30 days ago. What's next for the stock?

Wright Medical (WMGI) Down 7.8% Since Last Earnings Report: Can It Rebound?

Becton, Dickinson and Co.

Ford Motor Company

Fiat Chrysler

General Motors

Johnson & Johnson

Medtronic

NuVasive

Royal Philips

ResMed

Smith & Nephew

Stryker

Tesla

Zimmer Biomet Hlds

Some of the biggest medical device companies' stocks have dropped to attractive prices due to the current COVID-19 pandemic.

Can Medical Device Stocks Help Rebuild Your Portfolio?

Wright Medical (WMGI) is gaining traction from strong international presence and robust product portfolio. However, adverse forex continues to raise concerns.

Here's Why You Should Retain Wright Medical Stock For Now

Wright Medical Group (NASDAQ: WMGI), a medical device maker that caters to the orthopedic market, saw its stock rally by over 30% on Monday, after news emerged that it would be acquired by larger rival Stryker Corporation. Stryker will pay $30.75 in cash for each of Wright’s outstanding shares.

Why Was Wright Medical Group Stock Up 30% Last Monday?

Lancaster Colony

Optimistic investors sent the major benchmarks to record levels.

Why NIO, Wright Medical Group, and Lancaster Colony Jumped Today

Shares jump after the company accepts a buyout offer.

Why Wright Medical Group Stock Is Soaring Today

Wright Medical Group N.V. (NASDAQ: WMGI) shares exploded on Monday after the announcement that the firm would be acquired by Stryker Corp.

Are Wright Medical Shareholders Getting Enough in the Stryker Acquisition?

Stryker announced a $4 billion plan to acquire Wright Medical Group on Monday — sending the two medical technology stocks on a divergent path in premarket trading on the stock market.

Stryker Plots $4 Billion Takeover — And Its Target Rockets 30%

Shares of Wright Medical Group N.V. WMGI, +5.82% rocketed 32% toward a 3-month high in premarket trading Monday, after the medical device company announced an agreement to be bought out by Stryker Corp.

Wright Medical's stock rockets after Stryker buyout deal for 40% premium

AMSTERDAM, The Netherlands, Nov. 04, 2019 (GLOBE NEWSWIRE) -- Wright Medical Group N.V. (NASDAQ: WMGI) today announced that it has entered into a definitive agreement under which Stryker (NYSE: SYK) will acquire all of the issued and outstanding ordinary shares of Wright Medical Group N.V. for a total equity value of approximately $4.7 billion, including the value of Wright’s outstanding convertible notes, and total enterprise value of approximately $5.4 billion.

Wright Medical Group N.V. Announces Definitive Agreement to be Acquired by Stryker

Will Wright Medical Group (WMGI) Report Negative Earnings Next Week? What You Should Know

Strong international footprint, solid prospects in the global orthopedic space and an enhanced product pipeline bode well for Wright Medical (WMGI). However, adverse forex mars prospects.

Here's Why You Should Hold on to Wright Medical (WMGI) Stock

Calix

Ceridian HCM Holding Inc.

Palo Alto Networks

Abandoning toxic stocks at the right time is the key to safeguard your portfolio from big losses.

4 Toxic Stocks Investors Should Steer Clear Of Right Now

Company to Showcase CARTIVA® Synthetic Cartilage Implant, PROstep   ™    Minimally Invasive Surgery System, Total Ankle Continuum of Care and AUGMENT® Injectable Bone Graft

Wright Medical Group N.V. Highlights Recent Innovations and Clinical Data at the American Orthopaedic Foot & Ankle Society (AOFAS) 2019  Annual Meeting

Camping World Hlds

Exterran

Golden Entertainment

Generally overhyped toxic stocks are susceptible to outside shocks. Moreover, these stocks are loaded with a high level of debt.

4 Toxic Stocks to Dispose of or Sell Short for Solid Gains

Wright Medical's reported results weren't bad, but Cartiva and core foot revenues both disappointed and management lowered expectations by more than 3%.

Groundhog Day At Wright Medical, As The Lower Extremity Business Disappoints

President and CEO of Wright Medical Group Nv (30-Year Financial, Insider Trades) Robert J Palmisano (insider trades) bought 46,654 shares of WMGI on 08/12/2019 at an average price of $21.39 a share.

Wright Medical Group Nv (WMGI) President and CEO Robert J Palmisano Bought $997,929 of Shares

Wright Medical Group stock collapsed to a 15-month low Thursday after the medical devices implant company slashed its 2019 sales guidance on slower-than-expected second-quarter revenue.
The post Medical Devices CEO Braces For A 'Knife Fight' As Stock Collapses 22% appeared first on Investor's Business Daily.

Medical Devices CEO Braces For A 'Knife Fight' As Stock Collapses 22%

Wright Medical (WMGI) gains from Upper and Lower Extremities units in Q2; slashes 2019 view.

Wright Medical (WMGI) Earnings Beat in Q2, Guidance Slashed

Wright Medical Group NV (WMGI) CEO Robert Palmisano on Q2 2019 Results - Earnings Call Transcript

News for Wright Medical Group Stock (WMGI)